277 related articles for article (PubMed ID: 18090235)
1. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis.
Morinville VD; Lowe ME; Elinoff BD; Whitcomb DC
Pancreas; 2007 Nov; 35(4):308-12. PubMed ID: 18090235
[TBL] [Abstract][Full Text] [Related]
2. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
3. Hereditary pancreatitis in children: surgical implications with special regard to genetic background.
Schmitt F; Le Henaff G; Piloquet H; Leclair MD; David A; Heloury Y; Podevin G
J Pediatr Surg; 2009 Nov; 44(11):2078-82. PubMed ID: 19944211
[TBL] [Abstract][Full Text] [Related]
4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
5. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
Keiles S; Kammesheidt A
Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
[TBL] [Abstract][Full Text] [Related]
6. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses.
Rebours V; Boutron-Ruault MC; Jooste V; Bouvier AM; Hammel P; Ruszniewski P; Lévy P
Am J Gastroenterol; 2009 Sep; 104(9):2312-7. PubMed ID: 19550412
[TBL] [Abstract][Full Text] [Related]
7. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis.
Liu QC; Gao F; Ou QS; Zhuang ZH; Lin SR; Yang B; Cheng ZJ
Chin Med J (Engl); 2008 Jan; 121(2):108-11. PubMed ID: 18272034
[TBL] [Abstract][Full Text] [Related]
8. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
[TBL] [Abstract][Full Text] [Related]
9. Hereditary pancreatitis: clinical features and inheritance characteristics of the R122C mutation in the cationic trypsinogen gene (PRSS1) in six Spanish families.
de las Heras-Castaño G; Castro-Senosiaín B; Fontalba A; López-Hoyos M; Sánchez-Juán P
JOP; 2009 May; 10(3):249-55. PubMed ID: 19454815
[TBL] [Abstract][Full Text] [Related]
10. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
11. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
[TBL] [Abstract][Full Text] [Related]
12. The natural history of hereditary pancreatitis: a national series.
Rebours V; Boutron-Ruault MC; Schnee M; Férec C; Le Maréchal C; Hentic O; Maire F; Hammel P; Ruszniewski P; Lévy P
Gut; 2009 Jan; 58(1):97-103. PubMed ID: 18755888
[TBL] [Abstract][Full Text] [Related]
13. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary pancreatitis].
Jørgensen MT; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2003 Jan; 165(5):447-51. PubMed ID: 12599840
[TBL] [Abstract][Full Text] [Related]
15. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
[TBL] [Abstract][Full Text] [Related]
16. Hereditary pancreatitis and mutations of the cationic trypsinogen gene.
O'Reilly DA; Kingsnorth AN
Br J Surg; 2000 Jun; 87(6):708-17. PubMed ID: 10928807
[TBL] [Abstract][Full Text] [Related]
17. SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia.
Gullo L; Laghi L; Migliori M; Lucrezio L; Bianchi P; Randolph AE; Mantovani V; Bastagli L; Pezzilli R; Malesci A
Pancreas; 2008 Jul; 37(1):31-5. PubMed ID: 18580441
[TBL] [Abstract][Full Text] [Related]
18. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis.
Férec C; Raguénès O; Salomon R; Roche C; Bernard JP; Guillot M; Quéré I; Faure C; Mercier B; Audrézet MP; Guillausseau PJ; Dupont C; Munnich A; Bignon JD; Le Bodic L
J Med Genet; 1999 Mar; 36(3):228-32. PubMed ID: 10204851
[TBL] [Abstract][Full Text] [Related]
20. [Dutch patients with hereditary pancreatitis; high mutation frequency, relatively little pain].
Derikx MH; te Morsche RH; Jansen JB; Drenth JP
Ned Tijdschr Geneeskd; 2009; 153():A324. PubMed ID: 19857283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
